Non-invasive Neurally Adjusted Ventilatory Assist (NIV-Nava): Four-Year Experience in a Level III Neonatal Intensive Care Unit.
- 1Neonatology, São Francisco Xavier Hospital, Western Lisbon Local Health Unit, Lisbon, PRT.
- 2Pediatrics, Cascais Hospital Dr. José de Almeida, Lisbon, PRT.
Abstract
Introduction Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is a ventilation mode that uses the electrical activity of the diaphragm to synchronize respiratory support with the patient's spontaneous effort. It has emerged as a promising non-invasive modality for neonates. We aimed to evaluate the clinical success of NIV-NAVA in a neonatal intensive care unit (NICU) setting. To our knowledge, this is the first study in Portugal to describe the experience with NIV-NAVA in a level III NICU. Methods We conducted an observational retrospective cohort study through a medical record review over four years (January 2021 to December 2024). All newborns admitted to our NICU who were ventilated using NIV-NAVA were included. Descriptive statistical analysis was performed on demographic and diagnostic data. Ventilatory and gasometrical parameters, including fraction of inspired oxygen (FiO₂), pH, and partial pressure of carbon dioxide (pCO₂), were evaluated before and after NIV-NAVA initiation. A respiratory severity score (RSS) was calculated at baseline to assess the severity of respiratory disease. The primary outcome was the proportion of NIV-NAVA episodes not requiring subsequent endotracheal intubation, and success was defined as the avoidance of subsequent intubation. Results A total of 36 NIV-NAVA episodes were recorded across 28 newborns, with a mean gestational age of 26 weeks and a mean birth weight of 822g. All newborns were diagnosed with prematurity, respiratory distress syndrome, and bronchopulmonary dysplasia. The mean baseline RSS was 3.7, reflecting the respiratory disease burden at NIV-NAVA initiation. NIV-NAVA was initiated following extubation in 83.3% of cases and as therapeutic escalation in 16.7%. Success was achieved in 58.3% of all episodes (60% in the post-extubation group and 50% in the escalation group). No statistically significant differences were observed in mean FiO₂ or pCO₂ values before and after NIV-NAVA. Discussion NIV-NAVA success was observed in the majority of newborns, including extremely low birth weight infants with clinically relevant respiratory disease burden. While NIV-NAVA offers significant theoretical advantages regarding patient-ventilator synchronization, published evidence in the NICU remains limited. Conclusion Our findings support the use of NIV-NAVA as a feasible non-invasive ventilatory modality in preterm infants, particularly for post-extubation respiratory support, although further randomized controlled trials are warranted to better establish its role and efficacy within the neonatal population.
Related
- Effects of Neurally Adjusted Ventilatory Assist on Lung Ultrasound Aeration and Diaphragmatic Function in Extremely Preterm Infants With Evolving or Established Bronchopulmonary Dysplasia.
- The lived experience of critical care nurses caring for patients with intensive care unit-acquired weakness: a qualitative study
- Biofilm Formation on Invasive Medical Devices in Adult Intensive Care Units: A Scoping Review of Biomedical and Clinical Evidence
- Alternative to invasive bronchoscopy: validating tracheal aspirates for microbiome profiling in intensive care unit pneumonia patients
- Minimally Invasive Coronary Artery Bypass Grafting (MICS-CABG) Versus Conventional Off-Pump Coronary Artery Bypass Grafting (OPCAB): A Single-Center Analysis of Early Outcomes and Institutional Experience
BibTeX
@article{ferreira2026noninvasive,
title = {{Non-invasive Neurally Adjusted Ventilatory Assist (NIV-Nava): Four-Year Experience in a Level III Neonatal Intensive Care Unit.}},
author = {Madalena Ferreira and Margarida Roquette and Inês Belo and Cátia R Correia and Anabela Salazar},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116942},
url = {https://europepmc.org/article/MED/42928955},
note = {CC BY},
}
RIS
TY - JOUR
TI - Non-invasive Neurally Adjusted Ventilatory Assist (NIV-Nava): Four-Year Experience in a Level III Neonatal Intensive Care Unit.
AU - Madalena Ferreira
AU - Margarida Roquette
AU - Inês Belo
AU - Cátia R Correia
AU - Anabela Salazar
PY - 2026
DA - 2026/09/25
JO - Cureus
DO - 10.7759/cureus.116942
UR - https://europepmc.org/article/MED/42928955
AB - Introduction Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is a ventilation mode that uses the electrical activity of the diaphragm to synchronize respiratory support with the patient's spontaneous effort. It has emerged as a promising non-invasive modality for neonates. We aimed to evaluate the clinical success of NIV-NAVA in a neonatal intensive care unit (NICU) setting. To our knowledge, this is the first study in Portugal to describe the experience with NIV-NAVA in a level III NICU. Methods We conducted an observational retrospective cohort study through a medical record review over four years (January 2021 to December 2024). All newborns admitted to our NICU who were ventilated using NIV-NAVA were included. Descriptive statistical analysis was performed on demographic and diagnostic data. Ventilatory and gasometrical parameters, including fraction of inspired oxygen (FiO₂), pH, and partial pressure of carbon dioxide (pCO₂), were evaluated before and after NIV-NAVA initiation. A respiratory severity score (RSS) was calculated at baseline to assess the severity of respiratory disease. The primary outcome was the proportion of NIV-NAVA episodes not requiring subsequent endotracheal intubation, and success was defined as the avoidance of subsequent intubation. Results A total of 36 NIV-NAVA episodes were recorded across 28 newborns, with a mean gestational age of 26 weeks and a mean birth weight of 822g. All newborns were diagnosed with prematurity, respiratory distress syndrome, and bronchopulmonary dysplasia. The mean baseline RSS was 3.7, reflecting the respiratory disease burden at NIV-NAVA initiation. NIV-NAVA was initiated following extubation in 83.3% of cases and as therapeutic escalation in 16.7%. Success was achieved in 58.3% of all episodes (60% in the post-extubation group and 50% in the escalation group). No statistically significant differences were observed in mean FiO₂ or pCO₂ values before and after NIV-NAVA. Discussion NIV-NAVA success was observed in the majority of newborns, including extremely low birth weight infants with clinically relevant respiratory disease burden. While NIV-NAVA offers significant theoretical advantages regarding patient-ventilator synchronization, published evidence in the NICU remains limited. Conclusion Our findings support the use of NIV-NAVA as a feasible non-invasive ventilatory modality in preterm infants, particularly for post-extubation respiratory support, although further randomized controlled trials are warranted to better establish its role and efficacy within the neonatal population.
SN - 2168-8184
ER -